Veterinary Antibiotics Market Outlook (2023 to 2033)

The global veterinary antibiotics market is anticipated to be worth US$ 11,453.3 million in 2023. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8% and reach US$ 20,154.0 million by 2033.

The expanding animal healthcare industry, combined with the industry's ongoing innovation, is driving growth in the veterinary antibiotics market. Tetracycline is anticipated to hold a leading market share in the global demand for veterinary antibiotics based on product type. This is due to its widespread application in animals used for food production.

Additionally, the demand for veterinary antibiotics is facilitated by people's increased knowledge of how critical providing basic medical care for their pets is. The prevalence of zoonotic diseases and the implementation of legislation intended to stop the spread of animal diseases are just a few factors that have contributed significantly to the growth of the veterinary antibiotics market.

The growth of this market is anticipated to be further propelled by rising expenditures on animal healthcare, as well as increasing demand for pet insurance. It is anticipated that in the coming years, the untapped emerging markets such as China, India, and Brazil, as well as growth in the overall companion animal population, are expected to offer significant growth opportunities to the veterinary antibiotics market players.

Attribute Details
Veterinary Antibiotics Market Share (2022) US$ 10,911.5 million
Veterinary Antibiotics Market Share (2023) US$ 11,453.3 million
Veterinary Antibiotics Market Share (2033) US$ 20,154.0 million
Veterinary Antibiotics Market Share (2023 to 2033) 5.8%

On the other hand, only a limited amount of new antibiotics are being developed, there is a growing resistance to antimicrobials and antibiotics, and there is an increasing focus on good husbandry and hygiene practices. All of these factors are expected to impede the growth of the veterinary antibiotics market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Are the Key Drivers and Restraints of the Market?

Drivers:

It is anticipated that factors such as rising awareness about zoonotic disease, rising incidence of disease outbreaks in animals, and rising demand for food products derived from animals, promoting the veterinary antibiotics market share.

Moreover, the implementation of stringent regulations to prevent animal diseases, elevating the animal population, and increasing pet adoption are likely to drive the demand for veterinary antibiotics across the globe.

The sales of veterinary antibiotics are being driven upwards on a global scale by several factors, including the expanding market for pet health insurance and the rising cost of medical care.

Restraints:

In livestock, the spread of antibiotic-resistant microorganisms is a key concern. Pathogens found in food-producing animals can be transmitted to humans by direct contact between humans and animals or through the food chain and environmental exposure. An increase in people are dying as a result of antimicrobial-resistant diseases in the human population.

According to the World Health Organization, more than one-third of food-borne illness-related deaths occur in children under the age of five. Microbes, such as bacteria, are to blame for the majority of food-borne infections.

Infections caused by bacteria that are resistant to more than one class of antibiotics are becoming increasingly difficult to cure. As a result, veterinarians advise treating animals with lower concentrations of antibiotics.

As a result of these measures, antibiotic use around the world may be greatly reduced. This is expected to restrain the veterinary antibiotics market.

What are the Trends in the Veterinary Antibiotics Industry?

Opportunities:

Reduced anxiety, normalized blood pressure, fewer cardiac arrhythmias, and increased psychological well-being are all linked to the adoption of companion animals. These advantages have helped pet owners worldwide.

Since 2014, the United States dog population has grown from 77.8 million to 89.4 million, and the cat population has grown from 85.8 million to 95.6 million. The growth of allied sectors, such as animal antimicrobials and antibiotics, is anticipated to boost the need for veterinary antibiotics as pet owners' desire to invest in the health and well-being of their pets increases.

Threats:

An antimicrobial or an antibiotic is used to improve the health and productivity of livestock and companion animals. For the sake of animal health and efficacy, numerous authorities have established strict rules to approve animal pharmaceutical goods.

Veterinarian pharmaceutical products must meet rigorous standards set by these regulatory agencies before they may be approved. New veterinary pharmaceutical products, such as antimicrobials, vaccinations, parasiticides, and other pharmaceutical goods, are subject to strict regulatory criteria in countries such as Australia, Japan, and China.

Typically, it can take up to 11 years and cost 75 to 100 million dollars to have a veterinary drug approved in the United States and Europe (from product development to commercialization).

Additionally, it's understandable that the pharmaceutical industry is wary of investing in research and development of antimicrobial and antibiotic drugs to combat novel pathogens and parasite infections. This could be a huge challenge for the veterinary antibiotics market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Segment Analysis

Which is the Leading Segment in the Veterinary Antibiotics Market by Product?

In 2022, 48.20% of the global veterinary antibiotics market for animals was made up of tetracyclines. Tetracyclines have many benefits, such as being the most effective against pathogenic microorganisms, being easily absorbed, having low toxicity, and being cheap compared to other antimicrobial and antibiotic products for animals.

Due to these benefits, this product segment has a large share of the veterinary antibiotics market. During the forecast period, the fluoroquinolones segment is expected to grow at a rate of 8%.

Fluoroquinolones are used more by end users as they work better at low concentrations, get into tissues quickly, and can be given in different ways.

Which Route of Administration Segment is Leading the Veterinary Antibiotics Market?

In 2022, 46.10% of the global veterinary antibiotics market came from the premixes segment. The large share of this segment can be explained by the benefits of premixes, such as making it easier to give the medicine and less likely to change shape or absorb water.

During the period of the forecast, the injections segment is expected to have a substantial CAGR, at 4.9%. This veterinary antibiotic market share is expected to grow due to the benefits, like getting drugs right away and seeing their effects quickly.

Regional Analysis

What is the North America Growth Outlook for the Veterinary Antibiotics Market?

Owing to the rising animal farming, rising expenditures on animal healthcare, and rising demand for food products derived from animals, North America held the dominant revenue share of 35.6% in the global veterinary antibiotics market in 2022. This was due to the region's growing demand for animal food products.

According to a report published by the FDA in 2014, over 80% of all antibiotics sold in the United States were purchased for application in animal husbandry. According to the same source, the overall quantity of antibiotics administered to animals used for the production of food in the United States climbed by 16.1% between 2009 and 2012, reaching a total of 14.61 million kilos annually.

How is Asia Pacific Performing in the Veterinary Antibiotics Market?

During the forecast period, the Asia Pacific region is expected to increase at a CAGR of 5.4%. The APAC market for animal-derived food is growing as a result of factors such as an expanding animal population and an increased demand for animal-derived food products.

Due to the expanding poultry, meat, and dairy consumption and increasing awareness of animal health in emerging nations like India, the Asia Pacific veterinary antibiotics market is expected to grow at a faster rate in the region.

The veterinary antibiotics market study shows that national dietary changes in India have been documented. Meat intake among the young urban population has increased significantly over the past few decades.

As a result of the rising demand for animal proteins, fish, poultry, and pigs are now routinely bred with antibiotics to boost growth. In addition, the OECD reports that China is the world's leading producer of pork, with about 31.3 kg/capita produced in 2016, ahead of chicken and beef.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How are Start-ups Influencing the Veterinary Antibiotics Market?

Companies are increasingly partnering with other players to boost product innovation in the veterinary antibiotics industry. As the veterinary antibiotics industry becomes more competitive, new veterinary medications businesses are expanding into new markets and producing drugs by sharing their knowledge and expertise with other companies.

Growth in the veterinary antibiotics market is anticipated to be fueled by the rising use of pet insurance. The global pet insurance industry is virtually untouched, with exceptionally low penetration rates, giving a tremendous market opportunity for new startups to rise.

New companies are emerging in the veterinary antibiotics market and tapping the market potential.

How Key Players are Contributing to the Veterinary Antibiotics Market?

The veterinary antibiotics market is seeing an increase in collaboration between players. The primary reason is that collaborations provide companies access to a greater range of products and a more diverse technology set. Antibiotics generated as a result of this cooperation are of higher quality and manufactured faster.

Recent Developments Observed by FMI:

  • The 'Nandi' Portal was introduced in June 2023 to enable online approval of new veterinary drugs and vaccines in India. Nandi is an acronym for New Drug and Immunization Device Approval. As the entire form indicates, Nandi intends to make it easier for novel veterinary medications and vaccinations to receive NOCs.
  • For the Indian Pharmacopoeia (IP) 2022, the Indian Pharmacopoeia Commission (IPC) introduced seven new veterinary monographs and eight new chemical monographs with the intention of boosting both public and animal health in the nation. Carprofen pills, Pimobendan capsules, Selamectin, Tilmicosin, Tilmicosin injectable, and Triclabendazole are among the recently released veterinary monographs.
  • A partnership between the Pride Veterinary Medical Community and the United States-based animal health technology business Covetous was announced in June of 2021. Covetrus is situated in the United States. With the help of this partnership, Covetrus can offer cutting-edge veterinary medicine, which in turn empowers veterinary healthcare professionals.
  • Adiva GmbH and Bayer AG partnered to produce therapeutic antibodies for veterinary medicine in April 2019.

Key Players in the Global Market

  • Zoetis Inc.
  • Merck & Co.
  • Bayer AG
  • Sanofi
  • Eli Lilly and Company
  • Ceva Sante Animale
  • Others

Scope of the Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Regions Covered North America; Latin America; Europe; Asia Pacific; The Middle East & Africa (MEA)
Key Countries Covered United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others
Key Segments Covered Product Type, Route of Administration, Animal Type, Region
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Veterinary Antibiotics Market Segmentation

By Product Type:

  • Tetracyclines
  • Penicillins
  • Macrolides
  • Sulphonamides
  • Aminoglycosides
  • Others

By Route of Administration:

  • Premixes
  • Injections
  • Oral Powders
  • Oral Solutions
  • Others

By Animal Type:

  • Food-processing Animals
  • Companion Animals

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Veterinary Antibiotics Market in 2023?

The market is valued at US$ 11.4 billion in 2023.

Who are the Top Market Players?

Zoetis Inc., Merck & Co., and Bayer AG are the top market players.

What is the Growth Forecast for the Market?

The market is forecast to register a CAGR of 5.8% through 2033.

Which is the Key Segment by Product?

The Tetracyclines segment is likely to remain preferred through 2033.

Which is the Top Trend in the Veterinary Antibiotics Market?

Increasing awareness about the zoonotic disease is encouraging sales.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Tetracyclines

        5.3.2. Penicillins

        5.3.3. Macrolides

        5.3.4. Sulphonamides

        5.3.5. Aminoglycosides

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        6.3.1. Premixes

        6.3.2. Injections

        6.3.3. Oral Powders

        6.3.4. Oral Solutions

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis by Animal Type, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Animal Type, 2023 to 2033

        7.3.1. Food-producing Animals

        7.3.2. Companion Animals

    7.4. Y-o-Y Growth Trend Analysis by Animal Type, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis by Animal Type, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Route of Administration

        9.2.4. By Animal Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Route of Administration

        9.3.4. By Animal Type

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Route of Administration

        10.2.4. By Animal Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Route of Administration

        10.3.4. By Animal Type

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Route of Administration

        11.2.4. By Animal Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Route of Administration

        11.3.4. By Animal Type

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Route of Administration

        12.2.4. By Animal Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Route of Administration

        12.3.4. By Animal Type

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Route of Administration

        13.2.4. By Animal Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Route of Administration

        13.3.4. By Animal Type

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Route of Administration

        14.2.4. By Animal Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Route of Administration

        14.3.4. By Animal Type

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Route of Administration

        15.2.4. By Animal Type

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Route of Administration

        15.3.4. By Animal Type

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Route of Administration

            16.1.2.3. By Animal Type

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Route of Administration

            16.2.2.3. By Animal Type

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Route of Administration

            16.3.2.3. By Animal Type

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Route of Administration

            16.4.2.3. By Animal Type

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Route of Administration

            16.5.2.3. By Animal Type

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Route of Administration

            16.6.2.3. By Animal Type

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Route of Administration

            16.7.2.3. By Animal Type

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Route of Administration

            16.8.2.3. By Animal Type

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Route of Administration

            16.9.2.3. By Animal Type

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Route of Administration

            16.10.2.3. By Animal Type

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Route of Administration

            16.11.2.3. By Animal Type

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Route of Administration

            16.12.2.3. By Animal Type

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Route of Administration

            16.13.2.3. By Animal Type

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Route of Administration

            16.14.2.3. By Animal Type

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Route of Administration

            16.15.2.3. By Animal Type

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Route of Administration

            16.16.2.3. By Animal Type

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Route of Administration

            16.17.2.3. By Animal Type

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Route of Administration

            16.18.2.3. By Animal Type

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Route of Administration

            16.19.2.3. By Animal Type

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Route of Administration

            16.20.2.3. By Animal Type

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Route of Administration

            16.21.2.3. By Animal Type

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Route of Administration

            16.22.2.3. By Animal Type

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Route of Administration

            16.23.2.3. By Animal Type

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Route of Administration

        17.3.4. By Animal Type

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Zoetis, Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Merck & Co.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Bayer AG

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Sanofi

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Eli Lilly and Company

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Ceva Sante Animale

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Elanco Animal Health

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Virbac

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. HIPRA

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Lutim Pharma

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Veterinary Vaccines Market

February 2022

REP-GB-409

January 2023

326 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Veterinary Antibiotics Market